| Ident. | Authors (with country if any) | Title |
|---|
| 000C31 (2018) |
Cy V. Credille [États-Unis] ; Benjamin L. Dick [États-Unis] ; Christine N. Morrison [États-Unis] ; Ryjul W. Stokes [États-Unis] ; Rebecca N. Adamek [États-Unis] ; Nicholas C. Wu [États-Unis] ; Ian A. Wilson [États-Unis] ; Seth M. Cohen [États-Unis] | Structure-Activity Relationships in Metal-Binding Pharmacophores for Influenza Endonuclease. |
| 000C90 (2018) |
Min-Han Lin [Taïwan] ; David C. Moses [Taïwan] ; Chih-Hua Hsieh [Taïwan] ; Shu-Chun Cheng [Taïwan] ; Yau-Hung Chen [Taïwan] ; Chiao-Yin Sun [Taïwan] ; Chi-Yuan Chou [Taïwan] | Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes. |
| 000D48 (2017) |
Wahiba Aouadi [France] ; Cécilia Eydoux [France] ; Bruno Coutard [France] ; Baptiste Martin [France] ; Françoise Debart [France] ; Jean Jacques Vasseur [France] ; Jean Marie Contreras [France] ; Christophe Morice [France] ; Gilles Quérat [France] ; Marie-Louise Jung [France] ; Bruno Canard [France] ; Jean-Claude Guillemot [France] ; Etienne Decroly [France] | Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay |
| 000E83 (2017) |
Jin-Moo Lee [Corée du Sud] ; Jin-Beom Cho [Corée du Sud] ; Hee-Chul Ahn [Corée du Sud] ; Woong Jung [Corée du Sud] ; Yong-Joo Jeong [Corée du Sud] | A Novel Chemical Compound for Inhibition of SARS Coronavirus Helicase. |
| 001007 (2016) |
Vathan Kumar [Taïwan] ; Kian-Pin Tan [Taïwan] ; Ying-Ming Wang [Taïwan] ; Sheng-Wei Lin [Taïwan] ; Po-Huang Liang [Taïwan] | Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors. |
| 001049 (2016) |
Sheng Liu [République populaire de Chine] ; Yubin Li [République populaire de Chine] ; Wanxing Wei [République populaire de Chine] ; Kuiwu Wang [République populaire de Chine] ; Lisheng Wang [République populaire de Chine] ; Jianyi Wang [République populaire de Chine] | Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives. |
| 001089 (2016) |
Hanjun Zhao [République populaire de Chine] ; Jie Zhou [République populaire de Chine] ; Ke Zhang [République populaire de Chine] ; Hin Chu [République populaire de Chine] ; Dabin Liu [République populaire de Chine] ; Vincent Kwok-Man Poon [République populaire de Chine] ; Chris Chung-Sing Chan [République populaire de Chine] ; Ho-Chuen Leung [République populaire de Chine] ; Ng Fai [République populaire de Chine] ; Yong-Ping Lin [République populaire de Chine] ; Anna Jin-Xia Zhang [République populaire de Chine] ; Dong-Yan Jin [République populaire de Chine] ; Kwok-Yung Yuen [République populaire de Chine] ; Bo-Jian Zheng [République populaire de Chine] | A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses |
| 001304 (2015) |
Jin-Beom Cho [Corée du Sud] ; Jin-Moo Lee [Corée du Sud] ; Hee-Chul Ahn [Corée du Sud] ; Yong-Joo Jeong [Corée du Sud] | Identification of a Novel Small Molecule Inhibitor Against SARS Coronavirus Helicase. |
| 001529 (2014) |
Ying Sun [République populaire de Chine] ; Zidao Wang [République populaire de Chine] ; Jiali Tao [République populaire de Chine] ; Yi Wang [République populaire de Chine] ; Andong Wu [République populaire de Chine] ; Ziwen Yang [République populaire de Chine] ; Kaimei Wang [République populaire de Chine] ; Liqiao Shi [République populaire de Chine] ; Yu Chen [République populaire de Chine] ; Deyin Guo [République populaire de Chine] | Yeast-based assays for the high-throughput screening of inhibitors of coronavirus RNA cap guanine-N7-methyltransferase. |
| 001563 (2014) |
K B Wong [Hong Kong] ; D C C. Wan [Hong Kong] ; H F Chow [Hong Kong] | Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease. |
| 001594 (2014) |
C P Chuck [Hong Kong] ; Z H Ke [Hong Kong] ; C. Chen [Hong Kong] ; D C C. Wan [Hong Kong] ; H F Chow [Hong Kong] ; K B Wong [Hong Kong] | Profiling of substrate-specificity and rational design of broad-spectrum peptidomimetic inhibitors for main proteases of coronaviruses. |
| 001604 (2014) |
Yeong Hun Song ; Dae Wook Kim ; Marcus John Curtis-Long ; Heung Joo Yuk ; Yan Wang ; Ningning Zhuang ; Kon Ho Lee ; Kwon Seok Jeon ; Ki Hun Park | Papain-like protease (PLpro) inhibitory effects of cinnamic amides from Tribulus terrestris fruits. |
| 001652 (2014) |
Adeyemi O. Adedeji [États-Unis] ; Kamalendra Singh [États-Unis] ; Ademola Kassim [États-Unis] ; Christopher M. Coleman [États-Unis] ; Ruth Elliott [États-Unis] ; Susan R. Weiss [États-Unis] ; Matthew B. Frieman [États-Unis] ; Stefan G. Sarafianos [États-Unis] | Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses. |
| 001783 (2014) |
Adriaan H. De Wilde [Pays-Bas] ; Dirk Jochmans [Belgique] ; Clara C. Posthuma [Pays-Bas] ; Jessika C. Zevenhoven-Dobbe [Pays-Bas] ; Stefan Van Nieuwkoop [Pays-Bas] ; Theo M. Bestebroer [Pays-Bas] ; Bernadette G. Van Den Hoogen [Pays-Bas] ; Johan Neyts [Belgique] ; Eric J. Snijder [Pays-Bas] | Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture |
| 001785 (2014) |
Julie Dyall [États-Unis] ; Christopher M. Coleman [États-Unis] ; Brit J. Hart [États-Unis] ; Thiagarajan Venkataraman [États-Unis] ; Michael R. Holbrook [États-Unis] ; Jason Kindrachuk [États-Unis] ; Reed F. Johnson [États-Unis] ; Gene G. Jr Olinger [États-Unis] ; Peter B. Jahrling [États-Unis] ; Monique Laidlaw [États-Unis] ; Lisa M. Johansen [États-Unis] ; Calli M. Lear-Rooney [États-Unis] ; Pamela J. Glass [États-Unis] ; Lisa E. Hensley [États-Unis] ; Matthew B. Frieman [États-Unis] | Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection |
| 001961 (2013) |
Pillaiyar Thanigaimalai [Japon] ; Sho Konno ; Takehito Yamamoto ; Yuji Koiwai ; Akihiro Taguchi ; Kentaro Takayama ; Fumika Yakushiji ; Kenichi Akaji ; Shen-En Chen ; Aurash Naser-Tavakolian ; Arne Schön ; Ernesto Freire ; Yoshio Hayashi | Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studies. |
| 001966 (2013) |
Tao Liu [République populaire de Chine] ; Zhiyong Weng [République populaire de Chine] ; Xiaowu Dong [République populaire de Chine] ; Linjie Chen [République populaire de Chine] ; Ling Ma [République populaire de Chine] ; Shan Cen [République populaire de Chine] ; Naiming Zhou [République populaire de Chine] ; Yongzhou Hu [République populaire de Chine] | Design, Synthesis and Biological Evaluation of Novel Piperazine Derivatives as CCR5 Antagonists |
| 001C54 (2012) |
Adeyemi O. Adedeji [États-Unis] ; Kamalendra Singh ; Nicholas E. Calcaterra ; Marta L. Dediego ; Luis Enjuanes ; Susan Weiss ; Stefan G. Sarafianos | Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase. |
| 001D21 (2012) |
Thi Thanh Hanh Nguyen [Corée du Sud] ; Hye-Jin Woo ; Hee-Kyoung Kang ; Van Dao Nguyen ; Young-Min Kim ; Do-Won Kim ; Sul-Ah Ahn ; Yongmei Xia ; Doman Kim | Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris. |
| 001F84 (2012) |
Mi-Sun Yu [Corée du Sud] ; June Lee [Corée du Sud] ; JIN MOO LEE [Corée du Sud] ; Younggyu Kim [Corée du Sud] ; Young-Won Chin [Corée du Sud] ; Jun-Goo Jee [Corée du Sud] ; Young-Sam Keum [Corée du Sud] ; Yong-Joo Jeong [Corée du Sud] | Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13 |
| 002010 (2011) |
Qiaoli Li [République populaire de Chine] ; Zhenhuan Zhao ; Dihan Zhou ; Yaoqing Chen ; Wei Hong ; Luyang Cao ; Jingyi Yang ; Yan Zhang ; Wei Shi ; Zhijian Cao ; Yingliang Wu ; Huimin Yan ; Wenxin Li | Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses. |
| 002011 (2011) |
Thi Thanh Hanh Nguyen [Corée du Sud] ; Hwa-Ja Ryu ; Se-Hoon Lee ; Soonwook Hwang ; Vincent Breton ; Joon Haeng Rhee ; Doman Kim | Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation. |
| 002093 (2011) |
Prasenjit Mukherjee ; Falgun Shah ; Prashant Desai ; Mitchell Avery | Inhibitors of SARS-3CLpro: Virtual Screening, Biological Evaluation and Molecular Dynamics Simulation Studies |
| 002109 (2011) |
Xiaoqing Chen [République populaire de Chine] ; Zhongxia Wang ; Ziying Yang ; Jingjing Wang ; Yunxia Xu ; Ren-Xiang Tan ; Erguang Li | Houttuynia cordata blocks HSV infection through inhibition of NF-κB activation. |
| 002165 (2011) |
Mi Kyoung Kim [Corée du Sud] ; Mi-Sun Yu ; Hye Ri Park ; Kyung Bo Kim ; Chaewoon Lee ; Suh Young Cho ; Jihoon Kang ; Hyunjun Yoon ; Dong-Eun Kim ; Hyunah Choo ; Yong-Joo Jeong ; Youhoon Chong | 2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV). |
| 002434 (2010) |
R. Ramajayam [Taïwan] ; Kian-Pin Tan ; Hun-Ge Liu ; Po-Huang Liang | Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease. |
| 002450 (2010) |
Arun K. Ghosh [États-Unis] ; Jun Takayama [États-Unis] ; Kalapala Venkateswara Rao [États-Unis] ; Kiira Ratia [États-Unis] ; Rima Chaudhuri [États-Unis] ; Debbie C. Mulhearn [États-Unis] ; Hyun Lee [États-Unis] ; Daniel B. Nichols [États-Unis] ; Surendranath Baliji [États-Unis] ; Susan C. Baker [États-Unis] ; Michael E. Johnson [États-Unis] ; Andrew D. Mesecar [États-Unis] | Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Novel Protease Inhibitors: Design, Synthesis, Protein-Ligand X-ray Structure and Biological Evaluation |
| 002A13 (2009) |
M. Jalali-Heravi [Iran] ; M. Asadollahi-Baboli ; A. Mani-Varnosfaderani | Shuffling multivariate adaptive regression splines and adaptive neuro-fuzzy inference system as tools for QSAR study of SARS inhibitors. |
| 002A64 (2009) |
Andrea Spallarossa [Italie] ; Sara Cesarini ; Angelo Ranise ; Olga Bruno ; Silvia Schenone ; Paolo La Colla ; Gabriella Collu ; Giuseppina Sanna ; Barbara Secci ; Roberta Loddo | Novel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitors. |
| 002B01 (2009) |
Ying Guo [États-Unis] ; Jennifer Tisoncik ; Susanna Mcreynolds ; Michael Farzan ; Bellur S. Prabhakar ; Thomas Gallagher ; Lijun Rong ; Michael Caffrey | Identification of a new region of SARS-CoV S protein critical for viral entry. |
| 002B02 (2009) |
Melissa M. Coughlin [États-Unis] ; John Babcook ; Bellur S. Prabhakar | Human monoclonal antibodies to SARS-coronavirus inhibit infection by different mechanisms. |
| 002B77 (2009) |
Chaewoon Lee [Corée du Sud] ; Jin Moo Lee ; Na-Ra Lee ; Bong-Suk Jin ; Kyoung Jin Jang ; Dong-Eun Kim ; Yong-Joo Jeong ; Youhoon Chong | Aryl diketoacids (ADK) selectively inhibit duplex DNA-unwinding activity of SARS coronavirus NTPase/helicase. |
| 002B84 (2009) |
Weisheng Luo [République populaire de Chine] ; Xiaojian Su ; Shouji Gong ; Yongjun Qin ; Weibing Liu ; Jia Li ; Haiping Yu ; Qing Xu | Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. |
| 003059 (2008) |
Monica R. Loizzo [Italie] ; Antoine M. Saab ; Rosa Tundis ; Giancarlo A. Statti ; Francesco Menichini ; Ilaria Lampronti ; Roberto Gambari ; Jindrich Cinatl ; Hans Wilhelm Doerr | Phytochemical analysis and in vitro antiviral activities of the essential oils of seven Lebanon species. |
| 003072 (2008) |
Chunying Niu [Canada] ; Jiang Yin ; Jianmin Zhang ; John C. Vederas ; Michael N G. James | Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro. |
| 003123 (2008) |
Ka To Shum [Hong Kong] ; Julian A. Tanner | Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase. |
| 003511 (2008) |
Arun K. Ghosh [États-Unis] ; GANGLI GONG [États-Unis] ; Valerie Grum-Tokars [États-Unis] ; Debbie C. Mulhearn [États-Unis] ; Susan C. Baker [États-Unis] ; Melissa Coughlin [États-Unis] ; Bellur S. Prabhakar [États-Unis] ; Katrina Sleeman [États-Unis] ; Michael E. Johnson [États-Unis] ; Andrew D. Mesecar [États-Unis] | Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors |
| 003A34 (2007) |
William E. Severson [États-Unis] ; Nice Shindo ; Mindy Sosa [États-Unis] ; Thomas Fletcher [États-Unis] ; E. Lucile White [États-Unis] ; Subramaniam Ananthan [États-Unis] ; Colleen B. Jonsson [États-Unis] | Development and Validation of a High-Throughput Screen for Inhibitors of SARS CoV and Its Application in Screening of a 100,000-Compound Library |
| 003B21 (2007) |
Masahiro Ikejiri [Japon] ; Masayuki Saijo [Japon] ; Shigeru Morikawa [Japon] ; Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Ichiro Kurane [Japon] ; Tokumi Maruyama [Japon] | Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents |
| 003D11 (2006) |
Kap-Sun Yeung [États-Unis] ; Gregory A. Yamanaka ; Nicholas A. Meanwell | Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention. |
| 003E67 (2006) |
Hui Li [États-Unis] ; John Tatlock ; Angelica Linton ; Javier Gonzalez ; Allen Borchardt ; Peter Dragovich ; Tanya Jewell ; Tom Prins ; Ru Zhou ; Julie Blazel ; Hans Parge ; Robert Love ; Michael Hickey ; Chau Doan ; Stephanie Shi ; Rohit Duggal ; Cristina Lewis ; Shella Fuhrman | Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors. |
| 004973 (2005) |
Yu-San Han [République populaire de Chine] ; Gu-Gang Chang [République populaire de Chine] ; Chiun-Gung Juo [République populaire de Chine] ; Hong-Jen Lee [République populaire de Chine] ; Shiou-Hwei Yeh [République populaire de Chine] ; John Tsu-An Hsu [République populaire de Chine] ; Xin Chen [République populaire de Chine, Taïwan] | Papain-Like Protease 2 (PLP2) from Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV): Expression, Purification, Characterization, and Inhibition† |
| 005294 (2004) |
Els Keyaerts ; Leen Vijgen ; Piet Maes ; Johan Neyts ; Marc Van Ranst | In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine |
| 005500 (2004) |
Swee Kee Wong [États-Unis] ; Wenhui Li ; Michael J. Moore ; Hyeryun Choe ; Michael Farzan | A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2. |
| 006396 (2003) |
Christopher Mcguigan [Royaume-Uni] ; Alison Jukes [Royaume-Uni] ; Sally Blewett [Royaume-Uni] ; Hubert Barucki [Royaume-Uni] ; Jonathan T. Erichsen [Royaume-Uni] ; Graciella Andrei [Belgique] ; Robert Snoeck [Belgique] ; Erik De Clercq [Belgique] ; Jan Balzarini [Belgique] | Halophenyl furanopyrimidines as potent and selective anti-VZV agents |
| 006446 (2001) |
D J Hwang [Corée du Sud] ; S N Kim ; J H Choi ; Y S Lee | Dicaffeoyl- or digalloyl pyrrolidine and furan derivatives as HIV integrase inhibitors. |
| 006468 (2001) |
Chad E. Stephens [États-Unis] ; Takita M. Felder [États-Unis] ; J. Walter Sr Sowell [États-Unis] ; Graciela Andrei [Belgique] ; Jan Balzarini [Belgique] ; Robert Snoeck [Belgique] ; Erik De Clercq [Belgique] | Synthesis and antiviral/antitumor evaluation of 2-amino- and 2-carboxamido-3-arylsulfonylthiophenes and related compounds as a new class of diarylsulfones |
